Antibiotic resistance: a growing threat to human health
Infographic describing the issue of antibiotic resistance, its impact on public health, data, and possible solutions.Read more
Antibiotic resistance – an increasing threat to human health
Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden is comparable to that of inﬂuenza, tuberculosis and HIV/AIDS combined.Read more
Antimicrobial use in European hospitals and long-term care facilities
1 in 3 patients received at least one antimicrobial on any given day. Some of this use may be unnecessary and contribute to the spread of antimicrobial resistance.
Antimicrobial use in: Long-term care facilities
7 / 10 antimicrobials were prescribed for treatment of an infection and 3 in 10 for prophylaxis.
Healthcare-associated infections – a threat to patient safety in Europe
A total of 8.9 million HAIs were estimated to occur each year in European hospitals and long-term care facilitiesRead more
We work together to fight antibiotic resistance - Keeping Europeans healthy
How do EU agencies contribute to the fight against antimicrobial resistance? See a joint EMA/ECDC/EFSA/EEA infographicRead more
Infographic about antibiotic stewardship programmes
This infographic highlights the threat that antibiotic resistance poses and the effectiveness of antibiotic stewardship programmes to address the issue from different angles.Read more
Antibiotics: Be responsible
The infographic explains what antibiotic resistance is and highlights the extent of the problems that we are facing due to antibiotic resistance and antibiotic consumption in humans – in hospitals and in the community.Read more
How does antibiotic resistance spread?
This infographic explains how antibiotic resistance spreads in animal farming, in the community, in healthcare facilities and through travel.Read more
Antimicrobial resistance in Europe: 2014
Overview of the data on antimicrobial resistance in Europe released in 2014Read more
Growing resistance to last-line antibiotics: 2013
Carbapenems are a major last-line class of antibiotics to treat bacterial infections. The spread of carbapenem-resistant infections is a threat to healthcare and patient safety in Europe as it seriously curtails the ability to cure infections.Read more